These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 38630108)

  • 1. Mass Spectrometry Analysis of SARS-CoV-2 Nucleocapsid Protein Reveals Camouflaging Glycans and Unique Post-Translational Modifications.
    Sun Z; Zheng X; Ji F; Zhou M; Su X; Ren K; Li L
    Infect Microbes Dis; 2021 Sep; 3(3):149-157. PubMed ID: 38630108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass Spectrometry Analysis of Newly Emerging Coronavirus HCoV-19 Spike Protein and Human ACE2 Reveals Camouflaging Glycans and Unique Post-Translational Modifications.
    Sun Z; Ren K; Zhang X; Chen J; Jiang Z; Jiang J; Ji F; Ouyang X; Li L
    Engineering (Beijing); 2021 Oct; 7(10):1441-1451. PubMed ID: 32904601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein post-translational modification in SARS-CoV-2 and host interaction.
    Cheng N; Liu M; Li W; Sun B; Liu D; Wang G; Shi J; Li L
    Front Immunol; 2022; 13():1068449. PubMed ID: 36713387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable posttranslational modifications of severe acute respiratory syndrome coronavirus 2 nucleocapsid protein.
    Supekar NT; Shajahan A; Gleinich AS; Rouhani DS; Heiss C; Chapla DG; Moremen KW; Azadi P
    Glycobiology; 2021 Sep; 31(9):1080-1092. PubMed ID: 33997890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of SARS-CoV-2 spike and nucleocapsid proteins using isotope dilution tandem mass spectrometry.
    Pierce-Ruiz C; Santana WI; Sutton WJH; Fischler DA; Cooper HC; Marc LR; Barr JR; Williams TL
    Vaccine; 2021 Aug; 39(36):5106-5115. PubMed ID: 34344552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays.
    Semmler G; Traugott MT; Graninger M; Hoepler W; Seitz T; Kelani H; Karolyi M; Pawelka E; Aragón de La Cruz S; Puchhammer-Stöckl E; Aberle SW; Stiasny K; Zoufaly A; Aberle JH; Weseslindtner L
    J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33602698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting intra-viral conserved nucleocapsid (N) proteins as novel vaccines against SARS-CoVs.
    Thura M; Sng JXE; Ang KH; Li J; Gupta A; Hong JM; Hong CW; Zeng Q
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34519332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies.
    Ahmed SF; Quadeer AA; McKay MR
    Viruses; 2020 Feb; 12(3):. PubMed ID: 32106567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Spike Protein Post-Translational Modification Landscape and Its Impact on Protein Structure and Function via Computational Prediction.
    Liang B; Zhu Y; Shi W; Ni C; Tan B; Tang S
    Research (Wash D C); 2023 Mar; 6():0078. PubMed ID: 36930770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration.
    Yang Q; Hughes TA; Kelkar A; Yu X; Cheng K; Park S; Huang WC; Lovell JF; Neelamegham S
    Elife; 2020 Oct; 9():. PubMed ID: 33103998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Glycosylation and Disulfide Bonding of Wild-Type SARS-CoV-2 Spike Glycoprotein.
    Zhang S; Go EP; Ding H; Anang S; Kappes JC; Desaire H; Sodroski JG
    J Virol; 2022 Feb; 96(3):e0162621. PubMed ID: 34817202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited specificity of commercially available SARS-CoV-2 IgG ELISAs in serum samples of African origin.
    Emmerich P; Murawski C; Ehmen C; von Possel R; Pekarek N; Oestereich L; Duraffour S; Pahlmann M; Struck N; Eibach D; Krumkamp R; Amuasi J; Maiga-Ascofaré O; Rakotozandrindrainy R; Asogun D; Ighodalo Y; Kann S; May J; Tannich E; Deschermeier C
    Trop Med Int Health; 2021 Jun; 26(6):621-631. PubMed ID: 33666297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired systemic nucleocapsid antigen clearance in severe COVID-19.
    Bauer C; Mack E; Hefter V; Fischer A; Volland K; Skevaki C; Neubauer A; Gress T; Becker S; Keller C
    J Med Virol; 2023 Aug; 95(8):e29032. PubMed ID: 37581876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-tiered SARS-CoV-2 seroconversion screening in the Netherlands and stability of nucleocapsid, spike protein domain 1 and neutralizing antibodies.
    Garritsen A; Scholzen A; van den Nieuwenhof DWA; Smits APF; Datema ES; van Galen LS; Kouwijzer MLCE
    Infect Dis (Lond); 2021 Jul; 53(7):498-512. PubMed ID: 33684020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: Implications for vaccination and antibody therapeutics.
    Zhou D; Tian X; Qi R; Peng C; Zhang W
    Glycobiology; 2021 Jan; 31(1):69-80. PubMed ID: 32518941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
    Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 Infection Severity Is Linked to Superior Humoral Immunity against the Spike.
    Guthmiller JJ; Stovicek O; Wang J; Changrob S; Li L; Halfmann P; Zheng NY; Utset H; Stamper CT; Dugan HL; Miller WD; Huang M; Dai YN; Nelson CA; Hall PD; Jansen M; Shanmugarajah K; Donington JS; Krammer F; Fremont DH; Joachimiak A; Kawaoka Y; Tesic V; Madariaga ML; Wilson PC
    mBio; 2021 Jan; 12(1):. PubMed ID: 33468695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A New Cellular Interactome of SARS-CoV-2 Nucleocapsid Protein and Its Biological Implications.
    Min YQ; Huang M; Feng K; Jia Y; Sun X; Ning YJ
    Mol Cell Proteomics; 2023 Jul; 22(7):100579. PubMed ID: 37211047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinatorial Approach with Mass Spectrometry and Lectin Microarray Dissected Site-Specific Glycostem and Glycoleaf Features of the Virion-Derived Spike Protein of Ancestral and γ Variant SARS-CoV-2 Strains.
    Hiono T; Sakaue H; Tomioka A; Kaji H; Sasaki M; Orba Y; Sawa H; Kuno A
    J Proteome Res; 2024 Apr; 23(4):1408-1419. PubMed ID: 38536229
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.